Materials and Microfluidics: Enabling the Efficient Isolation and Analysis of Circulating Tumour Cells

Overview

Journal Chem Soc Rev

Specialty Chemistry

Date 2017 Jun 21

PMID 28632258

Citations 52

Authors

Joshua M Jackson

Malgorzata A Witek

Joyce W Kamande

Steven A Soper

Affiliations

Soon will be listed here.

Abstract

We present a critical review of microfluidic technologies and material effects on the analyses of circulating tumour cells (CTCs) selected from the peripheral blood of cancer patients. CTCs are a minimally invasive source of clinical information that can be used to prognose patient outcome, monitor minimal residual disease, assess tumour resistance to therapeutic agents, and potentially screen individuals for the early diagnosis of cancer. The performance of CTC isolation technologies depends on microfluidic architectures, the underlying principles of isolation, and the choice of materials. We present a critical review of the fundamental principles used in these technologies and discuss their performance. We also give context to how CTC isolation technologies enable downstream analysis of selected CTCs in terms of detecting genetic mutations and gene expression that could be used to gain information that may affect patient outcome.

Citing Articles

Advances and challenges in the use of liquid biopsy in gynaecological oncology.

Zhang Y, Tian L Heliyon. 2024; 10(20):e39148.

PMID: 39492906 PMC: 11530831. DOI: 10.1016/j.heliyon.2024.e39148.

Label-free detection and simultaneous viability determination of CTCs by lens-free imaging cytometry.

Li Y, Li Y, Wang X, Wang K, Li H, Wang P Anal Bioanal Chem. 2024; 417(1):95-107.

PMID: 39477899 DOI: 10.1007/s00216-024-05624-y.

Microfluidic Affinity Selection of B-Lineage Cells from Peripheral Blood for Minimal Residual Disease Monitoring in Pediatric B-Type Acute Lymphoblastic Leukemia Patients.

Witek M, Larkey N, Bartakova A, Hupert M, Mog S, Cronin J Int J Mol Sci. 2024; 25(19.

PMID: 39408948 PMC: 11477226. DOI: 10.3390/ijms251910619.

Emerging Advances in Microfluidic Hydrogel Droplets for Tissue Engineering and STEM Cell Mechanobiology.

Orabi M, Lo J Gels. 2023; 9(10).

PMID: 37888363 PMC: 10606214. DOI: 10.3390/gels9100790.

Circulating Tumor Cells Adhesion: Application in Biosensors.

Paglia E, Baldin E, Freitas G, Santiago T, Neto J, Silva J Biosensors (Basel). 2023; 13(9).

PMID: 37754116 PMC: 10526177. DOI: 10.3390/bios13090882.

References

Aceto N, Bardia A, Miyamoto D, Donaldson M, Wittner B, Spencer J . Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158(5):1110-1122. PMC: 4149753. DOI: 10.1016/j.cell.2014.07.013. View

de Bono J, Scher H, Montgomery R, Parker C, Miller M, Tissing H . Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008; 14(19):6302-9. DOI: 10.1158/1078-0432.CCR-08-0872. View

Kidess E, Jeffrey S . Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis?. Genome Med. 2013; 5(8):70. PMC: 3979136. DOI: 10.1186/gm474. View

Sarioglu A, Aceto N, Kojic N, Donaldson M, Zeinali M, Hamza B . A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nat Methods. 2015; 12(7):685-91. PMC: 4490017. DOI: 10.1038/nmeth.3404. View

Sabile A, Louha M, Bonte E, Poussin K, Vona G, Mejean A . Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection. Am J Clin Pathol. 1999; 112(2):171-8. DOI: 10.1093/ajcp/112.2.171. View

Tibbe A, Miller M, Terstappen L . Statistical considerations for enumeration of circulating tumor cells. Cytometry A. 2007; 71(3):154-62. DOI: 10.1002/cyto.a.20369. View

Ocana O, Corcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S . Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell. 2012; 22(6):709-24. DOI: 10.1016/j.ccr.2012.10.012. View

Mi Y, Li K, Liu Y, Pu K, Liu B, Feng S . Herceptin functionalized polyhedral oligomeric silsesquioxane - conjugated oligomers - silica/iron oxide nanoparticles for tumor cell sorting and detection. Biomaterials. 2011; 32(32):8226-33. DOI: 10.1016/j.biomaterials.2011.07.040. View

Pantel K, Speicher M . The biology of circulating tumor cells. Oncogene. 2015; 35(10):1216-24. DOI: 10.1038/onc.2015.192. View

10.

Talasaz A, Powell A, Huber D, Berbee J, Roh K, Yu W . Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci U S A. 2009; 106(10):3970-5. PMC: 2645911. DOI: 10.1073/pnas.0813188106. View

11.

Earhart C, Hughes C, Gaster R, Ooi C, Wilson R, Zhou L . Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips. Lab Chip. 2013; 14(1):78-88. PMC: 4144998. DOI: 10.1039/c3lc50580d. View

12.

Gao D, Vela I, Sboner A, Iaquinta P, Karthaus W, Gopalan A . Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014; 159(1):176-187. PMC: 4237931. DOI: 10.1016/j.cell.2014.08.016. View

13.

Svobodova Z, Kucerova J, Autebert J, Horak D, Bruckova L, Viovy J . Application of an improved magnetic immunosorbent in an Ephesia chip designed for circulating tumor cell capture. Electrophoresis. 2013; 35(2-3):323-9. DOI: 10.1002/elps.201300196. View

14.

Poudineh M, Aldridge P, Ahmed S, Green B, Kermanshah L, Nguyen V . Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking. Nat Nanotechnol. 2016; 12(3):274-281. DOI: 10.1038/nnano.2016.239. View

15.

M Jackson J, Witek M, Hupert M, Brady C, Pullagurla S, Kamande J . UV activation of polymeric high aspect ratio microstructures: ramifications in antibody surface loading for circulating tumor cell selection. Lab Chip. 2013; 14(1):106-17. PMC: 4182936. DOI: 10.1039/c3lc50618e. View

16.

Chen P, Huang Y, Hoshino K, Zhang J . Microscale magnetic field modulation for enhanced capture and distribution of rare circulating tumor cells. Sci Rep. 2015; 5:8745. PMC: 4348664. DOI: 10.1038/srep08745. View

17.

Papaioannou T, Stefanadis C . Vascular wall shear stress: basic principles and methods. Hellenic J Cardiol. 2005; 46(1):9-15. View

18.

Sharma T, Bruno J, Dhiman A . ABCs of DNA aptamer and related assay development. Biotechnol Adv. 2017; 35(2):275-301. DOI: 10.1016/j.biotechadv.2017.01.003. View

19.

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

20.

Gascoyne P, Shim S . Isolation of circulating tumor cells by dielectrophoresis. Cancers (Basel). 2014; 6(1):545-79. PMC: 3980488. DOI: 10.3390/cancers6010545. View